Evidence map›Paper›PMID 38098953›Full record

ArticlePlastic and reconstructive surgery. Global open2023

Enhanced Recovery after Surgery Protocol Decreases Length of Stay and Postoperative Narcotic Use in Microvascular Breast Reconstruction.

Corbin E Muetterties, Jeremiah M Taylor, Diana E Kaeding, Ricardo R Morales, Anissa V Nguyen, Lorna Kwan, Charles Y Tseng, Michael R Delong, Jaco H Festekjian

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07044583 narecruitingnot on this mapstarted 2025, after this paper: background citation

SAVE Trial: SAfe Opioid Use Video Education

TypeinterventionalSponsorUniversity of UtahRan2025 to 2027Enrolled68ConditionsBreast Reconstruction, Breast CancerArmsOpioid Educational Video
NCT07092475 phase3withdrawnnot on this mapstarted 2025, after this paper: background citation

The Impact of Intraoperative Methadone on Postoperative Opioid Use

TypeinterventionalSponsorUniversity of UtahRan2025 to 2025Enrolled0ConditionsBreast Cancer, Opioid UseArmsMethadon
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Corbin E MuettertiesFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
Jeremiah M TaylorFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
Diana E KaedingFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
Ricardo R MoralesFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
Anissa V NguyenFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
Lorna KwanFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
Charles Y TsengFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
Michael R DelongFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
Jaco H FestekjianFrom the Division of Plastic Surgery, University of California Los Angeles, Los Angeles, Calif.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Enhanced recovery after surgery (ERAS) protocols have demonstrated efficacy following microvascular breast reconstruction. This study assesses the impact of an ERAS protocol following microvascular breast reconstruction at a high-volume center. Methods: The ERAS protocol introduced preoperative counseling, multimodal analgesia, early diet resumption, and early mobilization to our microvascular breast reconstruction procedures. Data, including length of stay, body mass index, inpatient narcotic use, outpatient narcotic prescriptions, inpatient pain scores, and complications, were prospectively collected for all patients undergoing microvascular breast reconstruction between April 2019 and July 2021. Traditional pathway patients who underwent reconstruction immediately before ERAS implementation were retrospectively reviewed as controls. Results: The study included 200 patients, 99 in traditional versus 101 in ERAS. Groups were similar in body mass index, age (median age: traditional, 54.0 versus ERAS, 50.0) and bilateral reconstruction rates (59.6% versus 61.4%). ERAS patients had significantly shorter lengths of stay, with 96.0% being discharged by postoperative day (POD) 3, and 88.9% of the traditional cohort were discharged on POD 4 ( Conclusion: Implementing an ERAS protocol at a high-volume microvascular breast reconstruction center reduced length of stay and postoperative narcotic usage, without increasing pain or perioperative complications.

Identifiers

PMID38098953
PMCPMC10721129
OpenAlexW4389734041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.